However, taken individually, they reflect only one aspect of the NAFLD pathological scenery, i.e., hepatocyte apoptosis, inflammation, fibrosis, insulin sensitivity, and steatosis. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.